Beiersdorf Aktiengesellschaft (BIT:1BEI)

Italy flag Italy · Delayed Price · Currency is EUR
71.46
+0.48 (0.68%)
At close: Jun 17, 2026
Market Cap15.47B -40.7%
Revenue (ttm)9.85B +0.0%
Net Income939.00M +3.0%
EPS4.25 +4.8%
Shares Out n/a
PE Ratio16.48
Forward PE16.41
Dividend1.00 (1.42%)
Ex-Dividend DateApr 24, 2026
Volume50
Open71.70
Previous Close70.98
Day's Range71.46 - 72.12
52-Week Range67.38 - 111.65
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 5, 2026

About BIT:1BEI

Beiersdorf Aktiengesellschaft, together with its subsidiaries, manufactures and distributes consumer goods in Europe, the United States, Africa, Asia, and Australia. The company operates through two segments: Consumer Business and Tesa Business. The Consumer Business Segment offers skin and body care products. The Tesa Business segment provides adhesive tapes and self-adhesive solutions for industries, craft businesses, and consumers. This segment also offers its system solutions to the automotive, consumer electronics, printing and packaging, ... [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations
Founded 1882
Employees 21,589
Stock Exchange Borsa Italiana
Ticker Symbol 1BEI

Financial Performance

In 2025, BIT:1BEI's revenue was 9.85 billion, an increase of 0.02% compared to the previous year's 9.85 billion. Earnings were 939.00 million, an increase of 2.96%.

Financial Statements

News

Beiersdorf Aktiengesellschaft Transcript: AGM 2026

The AGM highlighted solid financial results amid a challenging market, with strategic focus on NIVEA's repositioning, innovation, and expansion in key markets. Shareholders approved all proposals, including a EUR 1 dividend and share buyback, while management addressed concerns on growth, acquisitions, and remuneration.

7 weeks ago - Transcripts

Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q1 2026

Q1 2026 saw a 4.6% organic net sales decline, with Derma delivering strong growth and Nivea and La Prairie facing headwinds. Early signs of improved sell-out and ongoing strategic rebalancing support a cautiously optimistic outlook for the year.

2 months ago - Transcripts

Beiersdorf Aktiengesellschaft Earnings release: Q1 2026

Beiersdorf Aktiengesellschaft released its Q1 2026 earnings on April 21, 2026, summarizing the period's financial results.

2 months ago - Filings

Beiersdorf Aktiengesellschaft Slides: Q1 2026

Beiersdorf Aktiengesellschaft has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 21, 2026.

2 months ago - Filings

Is Beiersdorf stock a buy after 44% crash? UBS upgrade offers key signals

Beiersdorf stock's long slump has finally been enough to make one major broker step back from its bearish stance. UBS upgraded the German skincare and consumer-goods group to “neutral” from “sell” on ...

2 months ago - Invezz

Beiersdorf Shares Fall on Sluggish 2026 Outlook

The cosmetics company expects slow sales this year, particularly in its consumer business segment.

3 months ago - WSJ

Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q4 2025

Despite a challenging year marked by market slowdowns and cost pressures, the group delivered modest sales and profit growth, driven by strong Derma performance and innovation. Strategic repositioning of NIVEA and continued investment in R&D and shareholder returns are key priorities.

3 months ago - Transcripts

Beiersdorf Aktiengesellschaft Annual report: Q4 2025

Beiersdorf Aktiengesellschaft has published its Q4 2025 annual report on March 3, 2026.

3 months ago - Filings

Beiersdorf Aktiengesellschaft Earnings release: Q4 2025

Beiersdorf Aktiengesellschaft released its Q4 2025 earnings on March 3, 2026, summarizing the period's financial results.

3 months ago - Filings

Beiersdorf Aktiengesellschaft Slides: Q4 2025

Beiersdorf Aktiengesellschaft has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 3, 2026.

3 months ago - Filings

Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q3 2025

Group organic sales grew 1.7% in Q3, led by double-digit derma growth, while NIVEA faced mass market headwinds but saw strong September momentum from new launches. Full-year guidance was adjusted to 2.5% organic growth, with EBIT margin improvement expected.

8 months ago - Transcripts

Beiersdorf Aktiengesellschaft Earnings release: Q3 2025

Beiersdorf Aktiengesellschaft released its Q3 2025 earnings on October 23, 2025, summarizing the period's financial results.

8 months ago - Filings

Beiersdorf Aktiengesellschaft Slides: Q3 2025

Beiersdorf Aktiengesellschaft has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 23, 2025.

8 months ago - Filings

Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q2 2025

Group organic sales grew 2.1% in H1 2025, with strong Derma and Healthcare segments offsetting NIVEA's softness. Major innovation launches, especially EPICELLINE, are set to drive a stronger H2, though full-year Consumer growth guidance was lowered to 3%-4%.

11 months ago - Transcripts

Beiersdorf Aktiengesellschaft Quarterly report: Q2 2025

Beiersdorf Aktiengesellschaft has published its Q2 2025 quarterly earnings report on August 6, 2025.

11 months ago - Filings

Beiersdorf Aktiengesellschaft Slides: Q2 2025

Beiersdorf Aktiengesellschaft has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 6, 2025.

11 months ago - Filings

Nivea-maker Beiersdorf's shares fall on lower sales forecast

Nivea-maker Beiersdorf's shares fell 10% on Wednesday after the company lowered its 2025 sales growth forecast late on Tuesday and warned of difficult market conditions.

11 months ago - Reuters

Switzerland investigates Beiersdorf in dispute over Nivea pricing

The Swiss competition authority said on Tuesday it has opened an investigation into Beiersdorf over whether the German consumer goods group has relative market power over Swiss retailer Migros in a di...

1 year ago - Reuters

Beiersdorf Sticks to Outlook After Solid Sales Growth

The personal-care products maker reported organic sales growth of 3.6% and backed its expectations for 2025.

1 year ago - WSJ

Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q1 2025

Group organic sales grew 3.6% in Q1, led by strong Derma and Tesa performance, while China repositioning and travel retail weighed on results. Guidance for 4%-6% organic growth and higher EBIT margin is maintained, with improvement expected in H2 as innovation launches accelerate.

1 year ago - Transcripts

Beiersdorf Aktiengesellschaft Earnings release: Q1 2025

Beiersdorf Aktiengesellschaft released its Q1 2025 earnings on April 15, 2025, summarizing the period's financial results.

1 year ago - Filings

Beiersdorf Aktiengesellschaft Slides: Q1 2025

Beiersdorf Aktiengesellschaft has posted slides in relation to its Q1 2025 quarterly earnings report, which was published on April 15, 2025.

1 year ago - Filings

Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q4 2024

Record sales and profit growth in 2024, with strong performance in Consumer and Derma segments, margin expansion, and continued innovation. 2025 guidance anticipates 4%-6% organic growth, margin improvement, and ongoing investment in sustainability and digital.

1 year ago - Transcripts

Beiersdorf Aktiengesellschaft Annual report: Q4 2024

Beiersdorf Aktiengesellschaft has published its Q4 2024 annual report on February 27, 2025.

1 year ago - Filings

Beiersdorf Aktiengesellschaft Slides: Q4 2024

Beiersdorf Aktiengesellschaft has posted slides in relation to its Q4 2024 quarterly earnings report, which was published on February 27, 2025.

1 year ago - Filings